Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis

Table 1 Age distribution of the patient

Age range (yr)	Case number (n)	%
Under 20	18	9.89
21-30	45	24.73
31-40	35	19.23
41-50	29	15.93
51-60	18	9.89
Above 60	37	20.33

Table 2 Incidence rate of abnormal-liver-function outcomes

	ALT	AST	LDH
Total cases (n)	182	182	139
Abnormal cases (n)	128	57	87
Ratio (%)	70.3	31.3	62.6

Table 3 Abnormal-liver-function outcomes before treatment vs after treatment

Cases (n)	ALT		AST		LDH
	Before	After	Before	After	Before	After
Total	182	166	182	164	122	105
Normal	93	85	133	145	46	81
Abnormal	89	81	49	19	76	24

Table 4 Therapeutic drugs in 182 SARS patients

	Antibiotics	Ribavirin	Methylpredisolone
Cases (n)	160	137	115
Rate of usage (%)	87.9	75.2	63.2

Table 5 The distribution of ribavirin treatment in 84 SARS patients

Treatment	Days 1-3	Days 4-5	Days 6-10	Days 11-20	Days 21-30	Days 30
Cases number	32	23	17	8	3	1
%	38.1%	27.4%	20.2%	9.5%	3.6%	1.2%